Proof of Usefulness Report

Glyphic Bio

Analysis completed on 2/4/2026

+461
Proof of Usefulness Score
Industry Mainstay

Glyphic Biotechnologies is a verified Series A biotechnology company ($39M+ funding) developing a high-potential protein sequencing platform (ProSE). While the project itself possesses significant innovation and market relevance, the submission provided contained low-quality, falsified user data (claiming 'everyone' and 'most people' as users), which necessitated severe penalties on Reach, Traction, and Response quality factors. The score reflects the company's strong underlying asset value and capital backing, adjusted downward for the poor submission quality and pre-commercial status.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+175.0
Audience Reach Impact+20.0
Technical Innovation+135.0
Evidence Of Traction+62.5
Market Timing Relevance+90.0
Functional Completeness+2.5
Subtotal+485
Usefulness Multiplierx0.95
Final Score+461

Project Details

Project URL
glyphic.bio
Description
Glyphic Biotechnologies is a biotechnology company developing a single-molecule, massively parallel protein sequencing platform. Their technology, Protein Sequencing by Expansion (ProSE™), aims to provide de novo protein sequencing with single-molecule sensitivity, enabling researchers to develop novel therapeutics and diagnostics and gain deeper insights into human biology and disease. Founded in 2021, the company is based in Berkeley, California.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline